Chesapeake Capital Corp IL Buys Shares of 6,399 Xylem Inc. $XYL

Chesapeake Capital Corp IL purchased a new position in Xylem Inc. (NYSE:XYLFree Report) in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 6,399 shares of the industrial products company’s stock, valued at approximately $944,000.

Several other large investors also recently made changes to their positions in XYL. AQR Capital Management LLC increased its holdings in shares of Xylem by 14.4% during the 1st quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company’s stock valued at $3,645,000 after acquiring an additional 3,900 shares during the last quarter. NewEdge Advisors LLC lifted its holdings in Xylem by 3.3% in the 1st quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company’s stock worth $496,000 after purchasing an additional 132 shares during the last quarter. Empowered Funds LLC lifted its holdings in Xylem by 56.1% in the 1st quarter. Empowered Funds LLC now owns 8,678 shares of the industrial products company’s stock worth $1,037,000 after purchasing an additional 3,120 shares during the last quarter. Savant Capital LLC boosted its position in Xylem by 23.3% during the second quarter. Savant Capital LLC now owns 5,884 shares of the industrial products company’s stock worth $761,000 after purchasing an additional 1,110 shares during the period. Finally, Profund Advisors LLC boosted its position in Xylem by 11.1% during the second quarter. Profund Advisors LLC now owns 2,736 shares of the industrial products company’s stock worth $354,000 after purchasing an additional 273 shares during the period. Institutional investors own 87.96% of the company’s stock.

Xylem Stock Performance

XYL opened at $119.88 on Friday. The company has a quick ratio of 1.28, a current ratio of 1.62 and a debt-to-equity ratio of 0.12. The stock’s 50 day moving average price is $133.97 and its two-hundred day moving average price is $139.90. The firm has a market capitalization of $29.15 billion, a P/E ratio of 30.58, a price-to-earnings-growth ratio of 1.72 and a beta of 1.17. Xylem Inc. has a 12-month low of $100.47 and a 12-month high of $154.27.

Xylem (NYSE:XYLGet Free Report) last issued its quarterly earnings results on Tuesday, February 10th. The industrial products company reported $1.42 EPS for the quarter, hitting analysts’ consensus estimates of $1.42. Xylem had a return on equity of 11.11% and a net margin of 10.59%.During the same quarter last year, the firm earned $1.18 earnings per share. The company’s quarterly revenue was up 6.3% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.350-5.560 EPS. On average, equities analysts forecast that Xylem Inc. will post 4.65 earnings per share for the current year.

Xylem announced that its board has initiated a stock repurchase program on Wednesday, February 25th that authorizes the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization authorizes the industrial products company to purchase up to 4.8% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s board of directors believes its stock is undervalued.

Xylem Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 24th. Investors of record on Tuesday, February 24th will be paid a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a yield of 1.4%. The ex-dividend date is Tuesday, February 24th. This is an increase from Xylem’s previous quarterly dividend of $0.40. Xylem’s dividend payout ratio is currently 43.88%.

Wall Street Analyst Weigh In

A number of research firms have recently commented on XYL. The Goldman Sachs Group set a $158.00 price target on shares of Xylem in a research report on Wednesday, February 11th. Zacks Research downgraded shares of Xylem from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 18th. Oppenheimer set a $165.00 target price on shares of Xylem in a research note on Thursday, February 12th. TD Cowen reiterated a “hold” rating on shares of Xylem in a report on Monday, February 23rd. Finally, UBS Group reissued a “buy” rating and set a $155.00 target price on shares of Xylem in a research report on Friday, February 13th. Nine analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, Xylem has a consensus rating of “Moderate Buy” and a consensus price target of $158.08.

Read Our Latest Research Report on Xylem

Xylem Profile

(Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

Recommended Stories

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.